Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-71 Cr₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr

What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?

The latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA is ₹-71 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-71 Cr
Mar2025₹-65 Cr
Mar2024₹-69 Cr
Mar2023₹198 Cr
Mar2022₹80 Cr

How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-71 Cr
Negative
Mar2025 ₹-65 Cr
Negative
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹198 Cr
148.81
Mar2022 ₹80 Cr -

Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,897.4 Cr 3.4% -10.6% 78.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.4%

-10.6%

78.1%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses